Medigen Vaccine Biologics Corp is a Taiwan-based company principally engaged in the development and manufacture of vaccines and biological agents. The Company is engaged in the research, design, development, manufacture, and sale of cell culture vaccines such as influenza vaccines, enterovirus vaccines and dengue vaccines, as well as other biological agents. The main products include enterovirus 71 vaccines (Envacgen), quadrivalent seasonal influenza vaccines, and coronavirus disease 2019 (COVID-19) vaccines. The Company primarily distributes products in Taiwan.
More about the company